478 related articles for article (PubMed ID: 17851245)
21. Treatment of dual diagnosis disorders.
Murthy P; Chand P
Curr Opin Psychiatry; 2012 May; 25(3):194-200. PubMed ID: 22395768
[TBL] [Abstract][Full Text] [Related]
22. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
23. Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study.
Swartz MS; Wagner HR; Swanson JW; Stroup TS; McEvoy JP; Canive JM; Miller DD; Reimherr F; McGee M; Khan A; Van Dorn R; Rosenheck RA; Lieberman JA
J Nerv Ment Dis; 2006 Mar; 194(3):164-72. PubMed ID: 16534433
[TBL] [Abstract][Full Text] [Related]
24. New antipsychotic agents: emerging clinical profiles.
Buckley PF
J Clin Psychiatry; 1999; 60 Suppl 1():12-7; discussion 28-30. PubMed ID: 10037165
[TBL] [Abstract][Full Text] [Related]
25. [Dual diagnosis psychosis and substance use disorders: theoretical foundations and treatment].
Gouzoulis-Mayfrank E
Z Kinder Jugendpsychiatr Psychother; 2008 Jul; 36(4):245-53. PubMed ID: 18654956
[TBL] [Abstract][Full Text] [Related]
26. Clozapine use in a forensic population in a New South Wales prison hospital.
Martin A; O'Driscoll C; Samuels A
Aust N Z J Psychiatry; 2008 Feb; 42(2):141-6. PubMed ID: 18197509
[TBL] [Abstract][Full Text] [Related]
27. Differing effects of antipsychotic medications on substance abuse treatment patients with co-occurring psychotic and substance abuse disorders.
Stuyt EB; Sajbel TA; Allen MH
Am J Addict; 2006; 15(2):166-73. PubMed ID: 16595355
[TBL] [Abstract][Full Text] [Related]
28. Novelty-seeking among schizophrenia patients with comorbid alcohol abuse.
Kim JH; Kim D; Park SH; Lee HB; Chung EK
J Nerv Ment Dis; 2007 Jul; 195(7):622-4. PubMed ID: 17632255
[TBL] [Abstract][Full Text] [Related]
29. Antipsychotic agents for the treatment of substance use disorders in patients with and without comorbid psychosis.
Zhornitsky S; Rizkallah E; Pampoulova T; Chiasson JP; Stip E; Rompré PP; Potvin S
J Clin Psychopharmacol; 2010 Aug; 30(4):417-24. PubMed ID: 20631559
[TBL] [Abstract][Full Text] [Related]
30. Clozapine use in patients with schizophrenia and a comorbid substance use disorder: A systematic review.
Arranz B; Garriga M; García-Rizo C; San L
Eur Neuropsychopharmacol; 2018 Feb; 28(2):227-242. PubMed ID: 29273271
[TBL] [Abstract][Full Text] [Related]
31. [Addiction and schizophrenia. Nosological, clinical and therapeutic questions. 2. Substance dependence and schizophrenia].
Soyka M
Fortschr Neurol Psychiatr; 1994 Jun; 62(6):186-96. PubMed ID: 8050773
[TBL] [Abstract][Full Text] [Related]
32. Psychiatric comorbidity in forensic psychiatry.
Palijan TZ; Muzinić L; Radeljak S
Psychiatr Danub; 2009 Sep; 21(3):429-36. PubMed ID: 19794370
[TBL] [Abstract][Full Text] [Related]
33. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
34. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
Mercier C; Bret P; Bret MC; Queuille E
Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
[TBL] [Abstract][Full Text] [Related]
35. [Description of medicosocial profiles of pharmacodependent subjects consulting addictology centres using a computerized database].
Landreat MG; Vigneau CV; Bronnec MG; Sebille-Rivain V; Venisse JL; Jolliet P
Encephale; 2011 Dec; 37(6):418-24. PubMed ID: 22137213
[TBL] [Abstract][Full Text] [Related]
36. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
[TBL] [Abstract][Full Text] [Related]
37. [Consumption patterns and motivation for use of addictive drugs in schizophrenic patients].
Lambert M; Haasen C; Mass R; Krausz M
Psychiatr Prax; 1997 Jul; 24(4):185-9. PubMed ID: 9340658
[TBL] [Abstract][Full Text] [Related]
38. [Schizophrenia and addiction. A frequent psychiatric dual diagnosis].
Wettig J
MMW Fortschr Med; 2001 May; 143 Suppl 2():67-70. PubMed ID: 11434263
[TBL] [Abstract][Full Text] [Related]
39. Is it time to consider comorbid substance abuse as a new indication for antipsychotic drug development?
Awad AG
J Psychopharmacol; 2012 Jul; 26(7):953-7. PubMed ID: 22170735
[TBL] [Abstract][Full Text] [Related]
40. [Comorbidity of alcohol-substance use disorders in schizophrenia: a review].
Evren EC; Evren B
Turk Psikiyatri Derg; 2003; 14(3):213-24. PubMed ID: 14569472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
